![Proposed Rule Puts Labs at Greater Risk of FCA Liability](https://www.g2intelligence.com/wp-content/uploads/2023/03/April23.NLR_.MedicareOverpaymentRules-iStock-1800x1250-1-1080x675.jpg)
Proposed Rule Puts Labs at Greater Risk of FCA Liability
CMS recently proposed a rule that would make the False Claims Act rule the standard for overpayments under the Affordable Care Act regulations.
CMS recently proposed a rule that would make the False Claims Act rule the standard for overpayments under the Affordable Care Act regulations.
Recently announced enforcement actions saw three big settlements, with two of those coming from medical centers.
Though labs were again absent from recent key enforcement actions, sentences were handed down in other healthcare-related cases.
In this month’s roundup of cases involving labs, Labcorp gets one lawsuit tossed and settles another.
As we move further into 2023, COVID-19, add-on, and genetic tests will likely remain targets for federal regulators.